Skip to main content

Table 2 Baseline echocardioraphic parameters of the study participants developing or not developing type 2 diabetes at the follow-up

From: Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study

Variable Total (n = 1817) Not developing type 2 diabetes (n = 1544) Developing type 2 diabetes (n = 273) P value
LA volume index (mL/m2) 26.2 ± 6.3 26.1 ± 6.3 26.7 ± 6.4 0.181
Relative wall thickness 0.37 ± 0.06 0.36 ± 0.06 0.39 ± 0.07 <0.001
LV mass (g) 150 ± 37 149 ± 37 158 ± 38 <0.001
LV mass index (g/m2) 87.3 ± 16.6 86.7 ± 16.4 91.2 ± 17.0 <0.001
LV hypertrophy (%) 13.9 13.1 18.7 0.017
LV ejection fraction (%) 65.0 ± 4.5 65.1 ± 4.5 64.7 ± 4.5 0.235
Mitral inflow velocity
 E, cm/s 0.68 ± 0.15 0.68 ± 0.15 0.66 ± 0.15 0.039
 A, cm/s 0.63 ± 0.17 0.62 ± 0.17 0.70 ± 0.18 <0.001
 E/A ratio 1.15 ± 0.36 1.17 ± 0.37 0.99 ± 0.30 <0.001
 DT, ms 195 ± 47 195 ± 47 200 ± 47 0.091
Tissue Doppler imaging (TDI)
 TDI Sm velocity (cm/s) 7.68 ± 1.29 7.70 ± 1.29 7.47 ± 1.27 0.018
 TDI Em velocity (cm/s) 7.57 ± 1.83 7.67 ± 1.80 7.47 ± 1.70 <0.001
E/Em ratio 9.31 ± 2.62 9.19 ± 2.55 10.23 ± 3.00 <0.001
LV diastolic dysfunction (%) 37.5 34.6 54.2 <0.001
  1. DT deceleration time, LA left atrium, LV left ventricle